fibrosis
Optimizing Pharmacotherapy In Chronic GVHD
Chronic graft-versus-host disease can occur in a multitude of organs, often characterized by fibrosis or ...
JUNE 13, 2025
Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial
Patients taking the glucagon/glucagon-like peptide-1 receptor dual agonist survodutide saw an 83% improvement in ...
AUGUST 9, 2024
VA Study Finds Alarming Gaps in Cirrhosis Diagnosis
New research has found that nearly half of patients who receive care at Veterans Health Administration hospitals ...
SEPTEMBER 10, 2021
Trial Results Mixed for Frontrunning NASH Therapy
For treatment of non-alcoholic steatohepatitis, obeticholic acid met one of its primary end points but not the ...
MARCH 18, 2020
Load more